SFDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages
SHANGHAI - Following industry comments, China's State FDA released another draft GMP guideline for which it seeks additional public comments. The revised draft offers clarity on a few key points but still leaves huge gaps that will need to be filled slowly over time